Pronađeno: 1-3 / 3 radova

Autori: Dellanna Frank

>> Prikaži sve rezultate

Naslov Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies (Article)
Autori Barratt Jonathan  Dellanna Frank  Portoles Jose  Choukroun Gabriel  De Nicola Luca  Young James  Dimkovic Nada B  Reusch Michael 
Info ADVANCES IN THERAPY, (2023), vol. 40 br. 4, str. 1546-1559
Projekat Astellas Pharma, Inc.; Astellas Pharma, Inc. [DOLOMITES: NCT02021318]; FibroGen, Inc. [SIERRAS: NCT02273726, HIMALAYAS: NCT02052310]; AstraZeneca [ROCKIES: NCT02174731]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies (Article)
Autori Barratt Jonathan  Dellanna Frank  Portoles Jose  Choukroun Gabriel  De Nicola Luca  Young James  Dimkovic Nada B  Reusch Michael 
Info ADVANCES IN THERAPY, (2023), vol. 40 br. 4, str. 1546-1559
Projekat Astellas Pharma, Inc. (DOLOMITES); FibroGen, Inc.; AstraZeneca; [NCT02021318]; [NCT02273726]; [NCT02052310]; [NCT02174731]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati:
Naslov The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study (Article)
Autori Locatelli Francesco  Spasovski Goce B  Dimkovic Nada B  Wanner Christoph  Dellanna Frank  Pontoriero Giuseppe 
Info NEPHROLOGY DIALYSIS TRANSPLANTATION, (2014), vol. 29 br. 5, str. 1061-1073
Projekat Mitsubishi Pharma Europe Ltd.
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX